Centene
Compensation Insight

How Centene Pays

Centene's analytical C1 to C4 and M1 to M4 ladder priced across 21 verified US markets, with 60/40 PSU and RSU executive equity, a quarterly ESPP at 95 percent of market price, a $19.51M CEO package at 206:1, and 96 H-1B records but no verified overseas workforce.

61,100 employees · NYSE: CNC · Centene Corporation · St. Louis, Missouri · FY ends 31 December
Team members
61,100
Reported at 31 December 2025, up about 600 on 60,500 a year earlier. Centene publishes no headcount by city, state or country.
CEO total pay
$19.51M
Sarah London's fiscal 2025 Summary Compensation Table total, of which $15.54 million was stock awards.
CEO pay ratio
206:1
Calculated against a $94,800 median employee and $19,516,298 of CEO compensation, $10,000 above the table total because the ratio adds medical benefits.
Median employee pay
$94,800
The 2026 proxy median-employee determination for fiscal 2025. Centene discloses no breakdown of that figure by function or location.
2025 incentive funding
71.6%
The enterprise annual cash incentive funded below target for every named executive, with no individual adjustment applied.
Stock compensation expense
$204M
Fiscal 2025 accounting expense, with a further $356 million unrecognised over about 2.1 years.
Employees holding awards
~2,650
Employee award-holders plus 11 directors at 15 March 2025, roughly 4.3 percent of the later 61,100 workforce.
H-1B median wage
$138,137
Median across 96 displayed 2025 labour condition applications; a second dataset counted 115 certified filings at a $137,841 average.
2026 severance estimate
$315M–$365M
Estimated severance expense for the remainder of 2026 after the voluntary separation program commenced on 27 July.
Locations
United States
1.00× base / 1.00× TC vs St. Louis

Band Hierarchy

Centene publishes named executive titles, individual job titles and a salary range on each posting. It publishes no universal band numbering, no job-family point system and no individual-contributor to management equivalency table. The C1 to C4 and M1 to M4 levels here are an analytical catalogue built from thirteen current Centene postings and the 2025 visa wage file; only the named executive rows carry a company disclosure.

Individual-contributor ladder — C1 through C4

C4
Lead / Principal / ArchitectIC · modeled
Lead Application Development Engineer, Lead Data Engineer, Principal Incident Response Analyst, Senior Business Solutions Architect, Enterprise Architect
C3
Senior Professional / Analyst / EngineerIC · modeled
Senior Business Technical Analyst, Senior Actuarial Analyst, Data Analyst IV, Senior Software Engineer
C2
Coordinator III / Professional IIC · modeled
Care Coordinator III, Business Operations Analyst, Developer I, Business Analyst II
C1
Frontline / Coordinator I–IIIC · verified
Care Coordinator I and II, member-service representative, claims and enrolment support, operations support

Management ladder — M1 through M4

M4
Vice President / Senior Vice PresidentManagement · modeled
Vice President of Network Development and Contracting, Vice President of Interoperability Strategy and Operations, Vice President and Associate General Counsel, Senior Vice President and health-plan chief executive
M3
Senior DirectorManagement · modeled
Senior Director of Healthcare Analytics, Senior Director of Medical Economics, Senior Director of Pharmacy
M2
DirectorManagement · modeled
Director of Care Management, Director of Operations, Director of Information Technology, Director and Process Owner
M1
Supervisor / Manager / Senior ManagerManagement · modeled
Supervisor of Care Coordination, Manager of Provider Data Management, Manager of Quality Improvement, Senior Manager of Product Performance

Executive — named executive officers

CEO
Chief Executive OfficerExecutive · variable 200% · verified
Chief Executive Officer and director
E2
EVP, Chief Financial OfficerExecutive · variable 150% · verified
Executive Vice President and Chief Financial Officer
E1
EVP / Chief OfficerExecutive · variable 100% · verified
Chief Operating Officer, Chief People Officer, EVP and General Counsel

Disclosed executive layer

Chief Executive Officer
Sarah M. London
Full proxy disclosure of salary, cash incentive, stock awards, other compensation, target mix and the 206 to 1 pay ratio.
Executive Vice President, Chief Financial Officer
Andrew L. Asher, with Christopher Neczypor joining as EVP around 1 September 2026 and becoming CFO on 1 January 2027
Full proxy disclosure for Asher; the incoming CFO's base, bonus target, long-term incentive target, make-whole award and sign-on payment are disclosed in the August 2026 Form 8-K.
Executive Vice Presidents and chief officers
Christopher A. Koster as EVP, Secretary and General Counsel, Susan R. Smith as Chief Operating Officer, Tanya M. McNally as Chief People Officer
Only officers who qualify as named executives appear in the compensation tables. Every other executive is visible through Section 16 filings alone.
Vice Presidents and Senior Vice Presidents
Health-plan chief executives, function leaders and associate general counsel roles
No compensation table exists for this layer. The only public numbers are the posted salary ranges on individual vice-president requisitions, which in 2026 ran from $171,900 at the bottom to $431,400 at the top.
VerifiedOnly the E1, E2 and CEO rows carry a company disclosure. Every band from C1 through M4 is reconstructed from official Centene job postings, cross-checked against the 2025 labour condition application file.

Track divergence

C1 to C3
Everyone sits on the individual-contributor path and pay is base salary as far as the public record goes. Frontline coordinator roles are quoted hourly and annualise between roughly $37,000 and $58,000, while the senior professional cluster runs to $157,800.
C3 onward
The tracks split. The technical route runs C3 to C4, where scope is technical authority, architecture and cross-enterprise influence. The leadership route runs C3 to M1, where scope is team size, budget, regulatory accountability and market ownership.
C4 against M1 and M2
The ladders overlap rather than stack. The C4 principal midpoint of about $166,300 sits above the M1 supervisor and manager midpoint of about $131,450, and a specialist senior director can outearn a vice president in another function.
M4 to the executive tier
This is not a mechanical promotion. It depends on succession planning, committee and board appointment, enterprise remit, external benchmarking and contract terms, and the pay structure changes shape completely because equity becomes the dominant component.

Hierarchy qualifications and legacy structures

  • Centene has never published a band chart, a grade midpoint, a compa-ratio or a range-penetration rule, so nothing in this catalogue should be quoted back as a Centene band. Every level here is an analytical overlay on official postings.
  • The bands are most reliable in technology, analytics and clinical operations, where postings and visa records overlap, and least reliable in sales, network contracting and corporate functions, where a single posting is the only evidence.
  • WellCare and Health Net remain visible in Centene's locations, titles and leadership biographies, but no public evidence supports a mapping from legacy grade codes to a harmonised Centene framework, so none is asserted here.
  • Vice President and Senior Vice President are corporate titles rather than a hidden grade number. The two current vice-president postings differ by $88,100 at the top of range, which is why M4 is shown as an envelope rather than a midpoint.
  • The three executive rows are actual fiscal 2025 outcomes for named individuals, not hiring ranges, and they are excluded from the range chart because a $19.5 million accounting total would flatten the employee ladder to a single line.
  • Assumed Magellan awards preserve equity for their existing holders only. They do not establish a parallel employee population or a separate current hierarchy.

Peer-level mapping

BandArchetypePeer mappingCaveat
C1Frontline / Coordinator I–IICoordinator or Analyst I at a managed-care peer; entry professional in technologyMany of these healthcare operations roles are hourly and licence-regulated, so a technology entry-level analogue understates the compliance load.Care Coordinator II posting of 14 August 2026 at $17.84 to $28.02 an hour, annualised at 2,080 hours for a $37,107 to $58,282 envelope.
C2Coordinator III / Professional IAnalyst II at a managed-care peer; entry to developing individual contributor in technologyThe envelope joins a clinical-operations coordinator to an entry technology professional, so the two endpoints are different labour markets rather than one job.Low from the Care Coordinator III posting of 21 August 2026 at $20.39 an hour annualised; high from an official entry-professional ceiling of $101,000. A 2025 Business Analyst II visa record in Irving sits at $82,650.
C3Senior Professional / Analyst / EngineerSenior analyst or senior engineer at a managed-care peer; senior individual contributor in technologyScope varies sharply across the clinical, actuarial, data and technology families, and Centene publishes no family-by-family range.Anchored on the Senior Business Technical Analyst posting of 11 July 2026 at $87,700 to $157,800, with a lower senior-role floor of $70,100. A 2025 Data Analyst IV visa record in Indianapolis sits at $131,330.
M1Supervisor / Manager / Senior ManagerSupervisor or manager at a managed-care peer; engineering or operations manager in technologySome Centene manager titles are effectively individual-contributor roles, so the title alone does not establish span of control.Envelope of $63,600 to $199,300 across supervisor and manager postings. The 24 August 2026 Manager of Provider Data Management posting is $70,100 to $126,200 and the 25 August 2026 Senior Manager of Product Performance posting is $107,700 to $199,300.
C4Lead / Principal / ArchitectLead, principal or architect at a managed-care peer; staff to principal individual contributor in technologyThere is no evidence of a single Centene principal ladder, so this row is a cluster of separately posted senior specialist roles.Senior Business Solutions Architect posting of 14 July 2026 at $107,700 to $199,300 and Principal Incident Response Analyst posting of 14 July 2026 at $121,500 to $224,900. 2025 visa records show a Lead Data Engineer in Tampa at $141,267 and Lead Application Development Engineers in St. Louis between $143,750 and $160,496.
M2DirectorDirector at a managed-care peer; director in technologyHeadcount and profit-and-loss scope vary materially between a plan-operations director and a corporate technology director on the same title.Envelope of $121,500 to $274,200 from official director postings, cross-checked against 2025 visa records at $207,041 for a Director of Information Technology in Tampa and $180,000 for a Director of Operations in Bridgeville. A third-party estimate puts a Director of Operations package at $154,755 base plus $29,726 bonus.
M3Senior DirectorSenior Director at a managed-care peer; senior director in technologyFunctional specialty drives a very wide envelope, and a licensed clinical or pharmacy remit can outpay a corporate senior director outright.Senior Director of Healthcare Analytics posting of 20 August 2026 at $134,600 to $249,000 and Senior Director of Pharmacy posting of 12 August 2026 at $185,700 to $352,500, the latter carrying California and licensed-clinical scope.
M4Vice President / Senior Vice PresidentVice President or Senior Vice President at a managed-care peer; vice president in technologyCentene publishes several vice-president ranges rather than one corporate target, so no single VP midpoint can be inferred from any two postings.Envelope of $171,900 to $431,400 across three current vice-president postings: Associate General Counsel at $171,900 to $326,900, Network Development at $180,400 to $343,300 and Interoperability at $227,700 to $431,400. None of the three states a bonus target or an equity grant.
E1EVP / Chief OfficerNamed executive officer or C-suite at a managed-care peerTotal is a grant-date accounting value dominated by stock awards, so it is not cash received and not a hiring range.Median of the three fiscal 2025 named executives carrying a 100 percent bonus target, which is Susan R. Smith as Chief Operating Officer on both salary and total. The cohort spans $3,172,356 for the Chief People Officer to $6,508,793 for the General Counsel.
E2EVP, Chief Financial OfficerChief Financial Officer at a managed-care peerAndrew Asher's 2025 stock award of $13.36 million is close to the chief executive's, so the CFO row is not a simple step below the CEO row.Andrew L. Asher's fiscal 2025 Summary Compensation Table row. His approved 2025 base was $1,200,000, a 17 percent increase and the largest of any named executive.
CEOChief Executive OfficerChief Executive Officer at Elevance, Cigna, Molina or UnitedHealthAbout 79.7 percent of the reported total is stock awards valued at grant, none of which is guaranteed to be realised.Sarah M. London's fiscal 2025 Summary Compensation Table row. Her approved 2025 base was $1,500,000, a 7 percent increase and her first since 2022.

Critical evidence warning

Centene publishes no bonus target, no equity grant value and no total-compensation figure for any role below the named executive tier. Its postings state only that total compensation may include additional forms of incentive. This report therefore shows bonus and equity as zero for every employee band rather than estimating a target, and the total column for those bands is base salary alone. Treat the employee rows as a base-salary market map, not as a package.


Compensation by Band — St. Louis

Low / median / high annual values at 1.00× base and 1.00× total-compensation factors versus St. Louis. Total equals base plus bonus plus annualized equity.

BandTitleBaseVariableTotal TCEquity
C1
Frontline / Coordinator I–II
0–3 years, role dependent · verified
$41K$55K
$48K
$41K$55K
C2
Coordinator III / Professional I
2–4+ years for the cited coordinator role · modeled
$61K$82K
$72K
$61K$82K
C3
Senior Professional / Analyst / Engineer
4–7+ years · modeled
$97K$131K
$114K
$97K$131K
M1
Supervisor / Manager / Senior Manager
5–10+ years plus people leadership · modeled
$112K$151K
$131K
$112K$151K
C4
Lead / Principal / Architect
5–10+ years · modeled
$141K$191K
$166K
$141K$191K
M2
Director
8–12+ years · modeled
$168K$228K
$198K
$168K$228K
M3
Senior Director
10–15+ years · modeled
$207K$280K
$244K
$207K$280K
M4
Vice President / Senior Vice President
10–15+ years of enterprise leadership · modeled
$256K$347K
$302K
$256K$347K
E1
EVP / Chief Officer
Board and committee appointed · verified
$611K$826K100%
$4.89M
$4.15M$5.62M
$3.58M
E2
EVP, Chief Financial Officer
Board and committee appointed · verified
$980K$1.33M150%
$16.07M
$13.66M$18.48M
$13.36M
CEO
Chief Executive Officer
Board appointed · verified
$1.25M$1.69M200%
$19.51M
$16.58M$22.43M
$15.54M
SEC filings and current job postings · 24 reported band cellsReportedModeledVerifiedBase and total are shown as a plus or minus 15 percent planning envelope around the analytical midpoint, and equity as plus or minus 25 percent. Centene's own posted ranges are wider and role-specific, and each band's actual posted endpoints are listed in its source note.

Total Compensation Range by Band

Total compensation in St. Louis across the employee bands. Proxy-disclosed executive cohorts are excluded so the employee bands stay readable.

C1$41K$55KC2$61K$82KC3$97K$131KM1$112K$151KC4$141K$191KM2$168K$228KM3$207K$280KM4$256K$347K$0$50K$100K$150K$200K$250K$300K$350K

Global Footprint & Pay Arbitrage

Centene reported 61,100 team members at 31 December 2025 and is a domestic United States employer. The current subsidiary exhibit is overwhelmingly domestic, the United Kingdom Circle Health business was sold in January 2024 and the Spanish and Central European operations were divested earlier, so no non-United States employing footprint was verified and none is priced here. St. Louis is the pay anchor.

61,100
Team members at 31 December 2025
21
Verified United States markets in this report
0
Verified non-United States employing entities
43%
Vice-president and above openings filled internally in 2025

Office and market catalogue — calibration factors versus St. Louis

LocationLikely office profilePresenceBaseTC
St. Louis
United States · USD
Headquarters, enterprise functions, technology and corporate leadershipSEC filings and current job postings1.00×1.00×
Clayton
United States · USD
Headquarters campus address for the corporate and finance organisationVerified corporate address in SEC filings1.00×1.00×
Tampa
United States · USD
Legacy WellCare hub covering technology, operations and health-plan functionsJob postings and 2025 visa worksite records1.01×1.01×
Wesley Chapel
United States · USD
Tampa Bay technology worksite carrying the highest Florida visa wages in the data2025 visa worksite records1.19×1.19×
Folsom
United States · USD
Northern California technology worksite with the highest observed wage level2025 visa worksite records1.30×1.30×
Irving
United States · USD
Texas analytics and business-analysis worksite, the lowest observed wage level2025 visa worksite records0.91×0.91×
Indianapolis
United States · USD
Indiana health-plan and data organisation, and the site of the employee ICHRA pilot2025 visa worksite records and proxy benefit disclosure1.00×1.00×
Orlando
United States · USD
Florida health-plan operations and member servicesActive market in the operating-footprint review1.00×1.00×
Charlotte
United States · USD
Health-plan and enterprise functions in the CarolinasActive market in the operating-footprint review1.00×1.00×
Chicago
United States · USD
Health-plan and care-management operationsActive market in the operating-footprint review1.00×1.00×
Atlanta
United States · USD
Health-plan and shared enterprise functions in the SoutheastActive market in the operating-footprint review1.00×1.00×
Austin
United States · USD
Texas health-plan and technology functionsActive market in the operating-footprint review1.00×1.00×
Phoenix
United States · USD
Arizona health-plan and care-management operationsActive market in the operating-footprint review1.00×1.00×
Tempe
United States · USD
Arizona operations and technology supportActive market in the operating-footprint review1.00×1.00×
Nashville
United States · USD
Tennessee health-plan and enterprise functionsActive market in the operating-footprint review1.00×1.00×
Sacramento
United States · USD
California health-plan operations under state pay-transparency posting rulesActive market in the operating-footprint review1.00×1.00×
Woodland Hills
United States · USD
Legacy Health Net hub for Southern California plan operationsActive market in the operating-footprint review1.00×1.00×
Long Beach
United States · USD
Southern California health-plan operations and member servicesActive market in the operating-footprint review1.00×1.00×
Columbus
United States · USD
Ohio health-plan operationsActive market in the operating-footprint review1.00×1.00×
Great Falls
United States · USD
Montana regional health-plan operations, the smallest verified marketActive market in the operating-footprint review1.00×1.00×
Remote / national
United States · USD
Remote, hybrid and field roles, the category most Centene postings are advertised underEvery cited 2026 posting names a remote or hybrid work arrangement1.00×1.00×

Centene reports total team members in its Form 10-K and nothing by office, state or country, so this catalogue does not rank markets by headcount. The twenty-one entries are the markets the operating-footprint review verified as active, plus the remote and national category that most 2026 postings are advertised under.

St. Louis anchor medians — the basis of every modeled cell

BandBaseStockBonusOtherTotal
C1$48K$0$0$48K
E1$718K$3.58M$514K$77K$4.89M
E2$1.15M$13.36M$1.24M$319K$16.07M
CEO$1.47M$15.54M$2.11M$386K$19.51M
  • St. Louis is the anchor because it is the headquarters city and carries the largest single block of observable wage evidence, at 24 of the 96 displayed 2025 labour condition applications with a median of $140,306.
  • Centene publishes no city differential schedule at all. Its own stated method is to read the range on the specific posting and the posting's lawful pay-adjustment clause, which is why seventeen of the twenty-one markets here sit at the anchor rather than carrying an invented multiplier.
  • Four markets carry an observed factor derived from the 2025 visa medians against the St. Louis median: Folsom at 1.30, Wesley Chapel at 1.19, Tampa at 1.01 and Irving at 0.91. All four samples are small, and Folsom, Wesley Chapel and Irving rest on four to five records each.
  • California markets are shown at the anchor even though state pay-transparency law forces Centene to post ranges there, because the only Californian wage observation in the bundle is Folsom, a technology worksite that is not representative of Sacramento, Woodland Hills or Long Beach plan operations.
  • The executive rows are enterprise disclosures for named individuals. They do not vary by city and should not be read as a local pay range in any selected market.

Model rules

  • Every employee cell is the St. Louis analytical midpoint multiplied by the market's base or total factor. There is no currency conversion in this report because every priced market is in the United States.
  • Factors come only from direct wage observations in the 2025 labour condition application file. Where a market has no observation the factor is 1.00, which reflects Centene's stated position that pay is set by the posting rather than by the city.
  • A total compensation cell is base plus target bonus plus annualised equity. Because Centene discloses no bonus target and no grant value below the executive tier, total equals base for every band from C1 through M4.
  • No employer benefit load is added anywhere in this report. Benefits are economically material at Centene but cannot be valued from the public plan summaries, and loading them into total compensation would turn employer cost into pay.
  • Executive rows reconcile exactly to the proxy: salary plus cash incentive plus stock awards plus all other compensation equals the Summary Compensation Table total, with all other compensation carried in its own column.

Variable Pay & Annual Cash Incentive

Centene discloses its executive annual cash incentive in full and discloses nothing about the employee bonus grid. Every current posting says only that total compensation may include additional forms of incentive, with no target percentage, no cadence, no weighting and no payout history. The band rows below therefore record the absence rather than estimating a number.

BandTargetMechanismRecent payout
C1
Frontline / Coordinator I–II
Not publicly disclosedPostings state that total compensation may include additional incentives, without naming a plan, a target or a cadence.Not publicly disclosed
C2
Coordinator III / Professional I
Not publicly disclosedNo enterprise target schedule for individual contributors was located in any filing, plan document or posting.Not publicly disclosed
C3
Senior Professional / Analyst / Engineer
Not publicly disclosedVisa wage records confirm base salary only. Labour condition applications exclude bonus, equity and benefits by construction.Not publicly disclosed
C4
Lead / Principal / Architect
Not publicly disclosedSenior specialist postings carry the same generic incentive language as frontline roles and quantify nothing.Not publicly disclosed
M1
Supervisor / Manager / Senior Manager
Not publicly disclosedNo public manager or director target grid was located. Offer documents may differ role by role.Not publicly disclosed
M2
Director
Not publicly disclosedOne third-party estimate splits a Director of Operations package into $154,755 of base and $29,726 of bonus, about 19 percent, but it is a modelled estimate on a very broad reported range and is not treated as a Centene target.Not publicly disclosed
M3
Senior Director
Not publicly disclosedSenior director postings disclose base range only, including the California and licensed-clinical roles that carry the widest envelope.Not publicly disclosed
M4
Vice President / Senior Vice President
Not publicly disclosedNone of the three current vice-president postings states a target bonus. The first quantified target in the public record is the 100 percent applied to named executive officers.Not publicly disclosed
E1
EVP / Chief Officer
100% of salaryEnterprise annual cash incentive weighted 60 percent adjusted diluted earnings per share, 20 percent organic premium and service revenue growth and 20 percent quality and strategic goals, each paying 0 to 200 percent.71.6% of target funded for fiscal 2025, with no individual adjustment
E2
EVP, Chief Financial Officer
150% of salarySame enterprise formula and same funding rate as the other named executives; only the target percentage differs.71.6% of target funded, paying $1,238,198 against a $1,729,327 opportunity
CEO
Chief Executive Officer
200% of salarySame enterprise formula, capped at 200 percent of target overall. The committee assessed performance and applied no individual adjustment for 2025.71.6% of target funded, paying $2,109,446 against a $2,946,154 opportunity
ModeledVerifiedThe uniform 71.6 percent funding rate across all five named executives is the single most useful fact in Centene's variable pay disclosure. It shows the plan has real downside, that the committee funded on the corporate result alone and that target compensation and realised cash are different quantities. For 2026 the design changes: the 20 percent organic premium and service revenue weighting is replaced by a 20 percent Health Benefits Ratio measure, moving the cash plan closer to medical cost performance and away from top-line growth.

Executive incentive targets — percent of salary

Chief Executive Officer
200% of salary
A $2,946,154 target opportunity for fiscal 2025, the largest cash opportunity in the company.
Executive Vice President, Chief Financial Officer
150% of salary
A $1,729,327 target opportunity. The incoming chief financial officer carries the same 150 percent target from 2027.
EVP, Secretary and General Counsel
100% of salary
A $768,269 target opportunity, the largest of the three named executives on a 100 percent target.
Chief Operating Officer
100% of salary
A $718,269 target opportunity, the median of the 100 percent target cohort.
Chief People Officer
100% of salary
A $654,808 target opportunity, the smallest disclosed named executive opportunity for 2025.

Named-executive outcomes

ExecutiveTargetPaidAttainment
Sarah M. London$2,946,154$2,109,44671.6%
Andrew L. Asher$1,729,327$1,238,19871.6%
Christopher A. Koster$768,269$550,08171.6%
Susan R. Smith$718,269$514,28171.6%
Tanya M. McNally$654,808$468,84371.6%

Employee payout timing and history

Nothing in the public record supports a broad-workforce payout history. The 71.6 percent rate applies to the named executive plan and must not be projected onto employee bonuses, and Centene has published no companywide salary hike, freeze, cut, campus offer revision or attrition figure for 2025 or 2026. The one enterprise pay event on record is the reverse of a bonus: a voluntary separation program with $315 million to $365 million of estimated severance expense for the rest of 2026.

Sales and special incentives

No sales commission plan, spot bonus schedule, referral award or utilisation-linked incentive was located in any Centene filing, plan exhibit or posting. Network contracting and provider-facing roles are advertised with the same generic incentive sentence as clinical and technology roles, so a sales-style variable structure cannot be inferred from title.


Equity — RSUs, PSUs, Options & ESPP

Centene runs three live share mechanisms and two legacy pools. The 2025 Stock Incentive Plan grants performance share units and restricted stock units to a selected population, the 2002 Employee Stock Purchase Plan lets any eligible employee buy at 95 percent of the quarterly closing price, and legacy Centene and Magellan awards remain outstanding without new grants. No stock options have been granted to employees since 2021.

Centene Corporation 2025 Stock Incentive Plan
Active
Verified
Permits stock options, stock appreciation rights, restricted stock, restricted stock units, performance share units and other stock-based awards. Options and rights are priced at no less than 100 percent of grant-date fair market value with a ten-year maximum term. Minimum vesting is one year with a limited exception bucket. Executive restricted stock units generally vest one third a year and performance share units generally cliff-vest after a three-year performance period. Awards remain subject to the plan, the award agreement and applicable clawback policies.
Reserve: 15,000,000 shares initially authorised on stockholder approval in 2025; 13,663,623 shares reported available for future issuance across all equity compensation plans at 31 December 2025.
2025 definitive proxy plan proposal and 2026 proxy equity compensation plan table
Centene Corporation 2002 Employee Stock Purchase Plan, as amended
Active
Verified
Generally open to employees after 90 days of service, with interns, per-diem and project-based workers excluded under the filed text. Payroll contributions run from 1 to 10 percent of pay against a compensation cap of $8,333.33 a month, offering periods begin in January, April, July and October, and shares are purchased at 95 percent of the closing market price on the quarterly exercise date. A $2,500 fair-value cap applies per quarter and purchased shares carry a 90-day holding requirement.
Reserve: 2,129,451 shares reported remaining at 31 December 2025, with approximately 796,000 shares issued during 2025.
Filed 2002 ESPP exhibit, the 2020 amendment and the 2025 Form 10-K
Prior Centene and 2012 plan awards
Legacy, outstanding only
Verified
Superseded for new grants. Existing awards continue under their original agreements, and the outstanding option population of roughly 393,047 shares at a $77.28 weighted average exercise price sits largely here. No employee stock options have been granted since 2021 and no named executive exercised an option in 2025.
Reserve: Included in the 11,701,303 securities reported outstanding under equity compensation plans at 31 December 2025.
2026 proxy equity compensation plan table
Magellan Health legacy plans
Legacy, outstanding only
Verified
Assumed on acquisition and closed to new grants. Awards vest and settle under the original Magellan agreements, and the population should not be read as a parallel employee equity pool.
Reserve: 2,948 restricted stock units and 236,975 options listed outstanding at 31 December 2025.
2026 proxy
  • A single pool utilisation rate is not determinable from Centene's public tables. Authorised shares, outstanding full-value awards, legacy assumed awards and future availability do not share a one-for-one denominator, and the aggregate table mixes several plans.
  • Restricted stock units dominate the outstanding population at roughly 11,548,179 units against about 393,047 options, so Centene's equity overhang is a full-value overhang rather than an option overhang.
  • Grant activity in 2025 was roughly 8.836 million restricted stock units granted, 2.593 million vested and 1.047 million forfeited, a gross grant rate far above the vesting rate.
  • Fiscal 2025 stock compensation expense was $204 million with a further $356 million unrecognised over about 2.1 years. That is an accounting expense, not a cash pool available for grants.
  • About 2,650 employees plus 11 directors held awards at 15 March 2025 against a 61,100 year-end workforce, roughly 4.3 percent. The dates do not match, so treat it as an indicative selectivity signal rather than a participation rate.

Equity plan position at 31 December 2025

11,701,303
Securities outstanding under equity plans
Mixes award types across current and legacy plans; not an ESOP pool used percentage.
13,663,623
Shares available for future issuance
Aggregate across all equity compensation plans, not a clean 2025-plan denominator.
~11,548,179
Restricted stock units outstanding
The dominant outstanding award category by a wide margin.
~393,047
Stock options outstanding
A small legacy population at a $77.28 weighted average exercise price.
2,129,451
ESPP shares remaining
About 796,000 shares were issued through the plan during 2025.
$204M
2025 stock compensation expense
With $356 million unrecognised over roughly 2.1 years.

Vesting — common reported employee schedule

Grant
0%
+Minimum one-year vesting applies under the plan · annual tranche
Year 1
33%
+One third of an executive restricted stock unit award · annual tranche
Year 2
67%
+One third · annual tranche
Year 3
100%
+Final third, and the point at which a three-year performance share unit cycle is certified · annual tranche

The one-third-a-year pattern is the executive restricted stock unit schedule disclosed in the proxy. Performance share units follow a different clock entirely: the 2025 cycle is certified and vests in March 2028 if earned, and settles anywhere between 50 and 200 percent of target. Centene has published no vesting schedule for any employee award below the executive tier, and the chief executive's January 2026 grant shows that even within the executive tier the schedules vary, splitting 138,859 units over three years and 69,429 units over five.

Eligibility by hierarchy level

  • Formal eligibility under the 2025 plan is broad, covering employees, officers, non-employee directors, consultants and advisors, but selection is entirely at the committee's discretion.
  • The correct answer to the question of a minimum band for restricted stock units is that it is not publicly disclosed. Eligibility language is not an entitlement and the 2,650 award-holder count shows how selective the practice is.
  • The Employee Stock Purchase Plan is the only clearly broad-based share mechanism, and the only one an employee can size for themselves through a 1 to 10 percent payroll election.
  • Vice-president postings do not state an equity grant, so even at the M4 level a candidate cannot read a grant expectation off the public record.
  • Executive equity is where the disclosure is complete: the 2025 long-term incentive mix was 60 percent performance share units and 40 percent restricted stock units for every named executive.

Indicative annual grant value by band — St. Louis

BandAnnual value (USD)MedianShares at $65
E1$2.68M$4.47M$3.58M~41,28268,804
E2$10.02M$16.70M$13.36M~154,188256,979
CEO$11.65M$19.42M$15.54M~179,282298,803

Annualized planning value (±25%), not the face value of every new-hire grant. Share equivalents use the $65 reference price at 25 August 2026 close and ignore plan valuation rules and PSU performance. Highlighted rows are disclosed grant-date stock awards.

Named executive target equity

ExecutiveTargetUnits / structure
Sarah M. London
Chief Executive Officer
$15,537,733 granted in fiscal 202560 percent performance share units and 40 percent restricted stock units. The January 2026 award was 520,720 securities: 138,859 three-year units, 69,429 five-year units and 312,432 target performance share units settling 0 to 200 percent through March 2029.
Andrew L. Asher
EVP, Chief Financial Officer
$13,362,923 granted in fiscal 2025Same 60/40 mix. The award is close enough to the chief executive's that the CFO row does not read as a step down on equity.
Christopher A. Koster
EVP, Secretary and General Counsel
$5,111,079 granted in fiscal 2025Same 60/40 mix, at about a third of the chief executive's grant value.
Susan R. Smith
Chief Operating Officer
$3,577,782 granted in fiscal 2025Same 60/40 mix.
Tanya M. McNally
Chief People Officer
$1,967,756 granted in fiscal 2025Same 60/40 mix, the smallest disclosed named executive grant for 2025.
Christopher Neczypor
Incoming Chief Financial Officer from 1 January 2027
$5.25M 2027 long-term incentive target plus a $10.0M make-whole awardThe make-whole restricted stock units vest in three equal annual instalments and sit alongside a $2.0 million cash sign-on payment. This is a lateral hiring package, not a standing executive grant level.
VerifiedCentene's plan is a 5 percent discount with no lookback, which is materially less valuable than the 15 percent discounted lookback plans common in large-cap technology. There is no offering-period reset and no purchase at the lower of two prices: shares are bought at 95 percent of the closing price on the quarterly exercise date, in January, April, July and October. A $2,500 fair-value cap applies per quarter and purchased shares must be held for 90 days. On roughly 796,000 shares issued in 2025 the aggregate discount is small in company terms, but for an individual employee it remains the only equity Centene will reliably let them have.

Executive Compensation

Fiscal 2025 named executive compensation from the 2026 definitive proxy statement. Stock awards are grant-date fair values under SEC and FASB rules and may never be realised, so the totals below are accounting values rather than cash received.

CEO total — Sarah M. London
$19.51M
Stock awards are 79.7% of the reported total; salary 8% and non-equity incentive 11%
8%
11%
80%
Salary $1.47M
Incentive $2.11M
Equity $15.54M
Salary$1,473,077
Non-equity incentive plan compensation$2,109,446
Stock awards$15,537,733
All other compensation$386,042
Reported total$19,506,298

Reading the package

Salary was about 7.6 percent of Sarah London's fiscal 2025 reported total and stock awards about 79.7 percent, so the headline number is overwhelmingly an equity instrument. Her total fell about 5.3 percent from $20.602 million in 2024 even though both salary and stock awards rose, because the cash incentive dropped from $4.289 million to $2.109 million when the plan funded at 71.6 percent. Her 2025 approved base of $1,500,000 was a 7 percent increase and her first since 2022.

CEO-to-median-employee ratio
206:1
Median employee $94,800 · The ratio divides $19,516,298 of chief executive compensation by a $94,800 median employee. The numerator is $10,000 higher than the $19,506,298 Summary Compensation Table total because the ratio calculation adds medical benefits, and Centene discloses both figures rather than reconciling them to one..
Peer CEO comparison
UnitedHealth Group · Stephen Hemsley · FY2025$60.95M
2026 definitive proxy
The Cigna Group · David Cordani · FY2025$22.87M
2026 definitive proxy
Elevance Health · Gail Boudreaux · FY2025$22.58M
2026 definitive proxy
Molina Healthcare · Joseph Zubretsky · FY2025$18.34M
2026 definitive proxy

Centene's $19.506 million sits below Cigna and Elevance and above Molina, which is roughly where its revenue scale would place it among managed-care peers. UnitedHealth's $60.951 million is not comparable because it includes a large one-time option award, and the comparison as a whole is limited by differing fiscal designs, award mixes and accounting treatments across the five proxies.


Named Executive Officers & Board

Centene's disclosed leadership layer is small: five named executive officers for fiscal 2025, plus a chief financial officer succession that spans 2026 and 2027. Everything below that layer is visible only through Section 16 filings and individual job postings.

Sarah M. London · Chief Executive Officer$19.51M
Salary $1.47M · Cash incentive $2.11M · Stock $15.54M · Other $386K · Equity 79.7%
Andrew L. Asher · EVP, Chief Financial Officer$16.07M
Salary $1.15M · Cash incentive $1.24M · Stock $13.36M · Other $319K · Equity 83.1%
Christopher A. Koster · EVP, Secretary and General Counsel$6.51M
Salary $768K · Cash incentive $550K · Stock $5.11M · Other $79K · Equity 78.5%
Susan R. Smith · Chief Operating Officer$4.89M
Salary $718K · Cash incentive $514K · Stock $3.58M · Other $77K · Equity 73.2%
Tanya M. McNally · Chief People Officer$3.17M
Salary $655K · Cash incentive $469K · Stock $1.97M · Other $81K · Equity 62%

The 2025 approved base salaries show differentiated market and scope adjustments rather than a single merit grid: London to $1,500,000 at 7 percent, Asher to $1,200,000 at 17 percent, Koster to $775,000 at 3 percent, McNally to $675,000 at 13 percent and Smith to $725,000 at 4 percent. The proxy notes that London, Asher and Koster had not received an increase since 2022 and cites increased scope and market positioning. The incoming chief financial officer's package is the clearest evidence of what lateral executive hiring costs at Centene: $1.1 million base, a 150 percent bonus target capped at 200 percent of target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three equal annual instalments and a $2.0 million cash sign-on payment.

Board compensation framework

ElementAmountNotes
Annual cash retainer$120,000Increased from $100,000 effective February 2026.
Annual restricted stock unit award$225,000Unchanged in the February 2026 update; units generally vest on the first anniversary of grant.
Independent chair additional cash$95,000Increased from $90,000 effective February 2026.
Independent chair additional restricted stock units$150,000On top of the standard $225,000 director award.
Committee chair additional cash$20,000–$30,000Varies by committee; selected committee-chair retainers rose to $25,000 in February 2026.

Eleven directors held equity awards at 15 March 2025. A director package of $120,000 cash plus $225,000 of restricted stock units is a governance retainer rather than an employment band, and it sits above the analytical M2 director midpoint of about $197,850 despite being part-time work, which is a useful reminder that the word director means two entirely different things in this company.

Regional heads and other officers

No compensation table exists for executives below the named officer tier. The only public number attached to the vice-president layer is the posted salary range on individual requisitions, and in 2026 those ran from $171,900 at the bottom of an associate general counsel range to $431,400 at the top of an interoperability range. Neither posting discloses a bonus target or an equity grant, so the step from M4 to E1 cannot be sized from public evidence.


Insider Trades — SEC Forms 3/4/5

Four Form 4 events between January and August 2026. Two are tax-withholding dispositions on vesting, which are mechanical and should not be read as insider selling; one is a grant; one is a genuine open-market sale.

DatePersonTransactionSharesPriceValue
2026-01-26
Sarah M. London
Chief Executive Officer
Award
Includes 138,859 three-year restricted stock units, 69,429 five-year restricted stock units and 312,432 target performance share units settling 0 to 200 percent with certification through March 2029. The Form 4 price field is $0; the value shown is an illustrative mark at the $65.00 reference price, not a grant-date fair value and not a realised amount.
520,720$33.85M
2026-03-15
Andrew L. Asher
EVP, Chief Financial Officer
Withholding
Code F: shares withheld to satisfy taxes on vesting, not an open-market sale. The $34.45 price is roughly half the August reference price, which is a useful marker of how far the shares moved during 2026.
15,241$34.45$525K
2026-06-15
Susan R. Smith
Chief Operating Officer
Withholding
Code F: a small tax-withholding disposition on vesting, again not a discretionary sale.
483$65.19$31K
2026-08-18
Christopher A. Koster
EVP, Secretary and General Counsel
Sale
Code S: a genuine open-market sale at a weighted average price, with individual executions between $65.28 and $65.45. This is the only discretionary disposition in the window and the only one above $3 million.
47,603$65.36$3.11M

Reading guide

Vesting is where executives actually realise valueThe 2026 proxy reports no named executive option exercises in 2025 and instead records shares acquired on restricted and performance share vesting: London 94,285 shares for $5,799,725, Asher 57,762 for $3,396,166, Smith 19,654 for $1,092,582, Koster 17,750 for $1,089,771 and McNally 7,543 for $459,182.
Code F is not a sell signalTwo of the four 2026 filings are code F tax withholdings. They happen automatically when an award vests, the executive chooses neither the timing nor the size, and labelling them insider selling would misread the filing.
One filing crosses the large-trade thresholdKoster's August 2026 sale of 47,603 shares for about $3.11 million is the only transaction in the window large enough to warrant separate attention, and it came three weeks after the voluntary separation program commenced.
The January grant is a quantity, not a valueLondon's 520,720 securities include performance share units that can settle anywhere between zero and double. Multiplying the headline share count by any market price overstates what is certain to be delivered.

Benefits & Perks

Centene's benefits are documented at category level on its official careers pages and almost nowhere at formula level. The categories below are verified; the contribution percentages, premium shares, day counts and reimbursement caps behind them are not published, and this report marks that gap rather than filling it with market norms.

United States

  • HealthMedical, dental and vision insurance. Offered to eligible employees. Carrier, employee premium and employer contribution schedule are not publicly itemised in any Centene source. [official]
  • HealthIndiana employee ICHRA pilot. About 600 Centene employees are enrolled in an individual marketplace plan through an employee individual coverage health reimbursement arrangement, most choosing Gold or Platinum, with the employer subsidy covering all or most of the employee premium. It is a specific program, not a nationwide contribution formula. [official]
  • ProtectionShort- and long-term disability. Confirmed as offered. Coverage multiples, elimination periods and premium splits are not disclosed. [official]
  • ProtectionSupplemental life and accidental death insurance. Confirmed as offered. Multiples of salary and employee cost are not disclosed. [official]
  • Retirement401(k) with company match and Roth option. The match itself is confirmed on the official benefits page, but the current match percentage and vesting schedule could not be traced to an authoritative plan document. A crowd-reported 50 percent on the first 6 percent is widely repeated and is not treated as verified here. [official]
  • Equity2002 Employee Stock Purchase Plan. Eligible generally after 90 days. Payroll deductions of 1 to 10 percent buy shares at 95 percent of the closing price on the quarterly exercise date in January, April, July and October, with a $2,500 fair-value cap per quarter and a 90-day holding requirement. [official]
  • Spending accountsHealthcare, dependent-care and commuter flexible spending accounts. Offered. Contribution limits and any employer seeding are not disclosed. [official]
  • Time offVacation, personal and sick time plus company holidays. Confirmed as offered. The standard day or hour accrual by tenure is not officially published, and crowd-reported hour totals were not promoted to verified terms. [official]
  • FamilyBirth-parent leave up to 14 weeks. The longest single leave entitlement Centene discloses. Eligibility and pay mechanics are subject to the plan. [official]
  • FamilyCaregiver leave up to 6 weeks. For care of an immediate family member. Eligibility is subject to the plan. [official]
  • FamilyAdoption reimbursement and family support. Adoption reimbursement, parenting resources and backup dependent-care references are named on the benefits page; the reimbursement limit is not public. [official]
  • LearningTuition reimbursement. Confirmed as offered. The annual reimbursement cap is not published. [official]
  • LearningCentene University. An enterprise learning organisation covering leadership, operations, technology, mentoring and career development, described as available to employees including part-time team members. [official]
  • WellbeingEmployee assistance program, wellness and fitness access. An employee assistance program plus wellness programming and fitness-centre or discount access at many locations. Availability varies by site. [official]
  • Work modelRemote, hybrid, field and office schedules. The 10-K describes a majority remote or hybrid workforce, and every 2026 posting cited in this report is advertised as remote or hybrid. It is a role-dependent arrangement, not a universal entitlement. [official]
  • CommunityPaid volunteer opportunities. Named on the official benefits summary. The annual hour allowance is not stated. [official]

Global programs

  • EnterpriseCentene University and development programs. Described as available across the enterprise, including part-time team members, with programs spanning leadership, operations, technology, mentoring and career development plus selected external development collaborations. [official]
  • EnterpriseCulture survey and employee networks. More than 35,000 employees took part in the 2025 annual culture survey and nearly 90 percent participated in at least one survey or engagement instrument. Employee professional networks are described but not enumerated. [official]
  • EnterpriseInternal mobility and succession. Centene reports that 43 percent of vice-president and above openings were filled internally in 2025, and that succession plans were delivered for 30 critical roles and 30 additional key-talent roles. [official]
  • Outside the United StatesIndia. No current Centene India employing entity or benefits schedule was verified, so employer provident fund contribution, gratuity policy, group medical and term life cover, leave entitlements, maternity and paternity policy, meal and transport allowances and relocation support are all not applicable on the evidence available. Indian statutory minimums are not substituted for company policy here. [npd]
  • Outside the United StatesAustralia and New Zealand. No current employing footprint was verified, so company-specific superannuation, leave, private health cover, salary packaging and wellness terms are not disclosed. [npd]
  • Outside the United StatesUnited Kingdom and Europe. Circle Health Group was sold in January 2024 and the Spanish and Central European operations were divested earlier, so legacy hospital and clinic benefits must not be presented as current Centene benefits. [npd]

Benefit fields not publicly quantified

Centene shows only one benefit region in this report because the operating-footprint review verified only one. The gaps inside that region are real and specific: the 401(k) match formula and vesting schedule, the paid-time-off day count by tenure, the employer share of medical premiums, the tuition reimbursement cap, the adoption reimbursement limit and the volunteer hour allowance are all confirmed to exist and none is published. Employee-reported figures circulate for several of these and are deliberately not promoted to verified plan terms.


Performance Review & Pay Progression

Centene describes a pay-for-performance philosophy, performance reviews at key milestones, culture and engagement monitoring and succession planning for critical roles. It publishes no rating scale, no distribution and no merit matrix for general employees, and this report shows that absence rather than manufacturing a grid.

Not publicly disclosed

General employee performance rating scale, including whether one exists at all
Rating labels such as Outstanding, Exceeds or Meets
Forced ranking or bell-curve distribution rules
Percentage distribution of employees by rating
Merit increase percentage mapped to rating
Standard annual hike percentage for any year
Promotion time-in-band expectations at any level
Promotion increase percentage
Probation and confirmation process
Individual-contributor versus manager calibration rules
Enterprise review month and merit effective date
Attrition rate for 2024, 2025 or 2026

Modeled promotion planning timeline

BandYears to next scopePromotion hikeStatus
C1Not publicly disclosedNot disclosedModeled planning interval
C2Not publicly disclosedNot disclosedModeled planning interval
C3Not publicly disclosedNot disclosedModeled planning interval
M1Not publicly disclosedNot disclosedModeled planning interval
C4Not publicly disclosedNot disclosedModeled planning interval
M2Not publicly disclosedNot disclosedModeled planning interval
M3Not publicly disclosedNot disclosedModeled planning interval
M4Not publicly disclosedNot disclosedModeled planning interval
E1Appointment, not promotion; depends on succession planning and board approvalNot disclosedModeled planning interval
E2Appointment, not promotion; succession announced for 1 January 2027Not disclosedModeled planning interval
CEOBoard appointmentNot disclosedModeled planning interval

The only quantified internal progression evidence Centene publishes is at the top of the house: 43 percent of vice-president and above openings were filled internally in 2025, succession plans were delivered for 30 critical roles and 30 additional key-talent roles, more than 35,000 employees took the annual culture survey and nearly 90 percent engaged with at least one instrument. These show an active talent process. They reveal nothing about promotion odds, calibration or pay outcomes below the executive layer.

Pay progression evidence

The 2025 named executive base increases of 3, 4, 7, 13 and 17 percent are the only pay-progression numbers in the public record, and their spread is the point: they reflect role scope, time in position, individual performance, leadership potential, internal benchmarking and peer market data rather than a single merit grid. Nothing in the filings suggests those percentages apply to the broader workforce, and the 2026 voluntary separation program makes any assumption of a routine annual merit cycle for 2026 unsafe.


H-1B / LCA Visa Footprint — United States

Centene is a small, technology-concentrated visa sponsor rather than a bulk filer. Roughly a hundred labour condition applications a year, clustered in St. Louis and Tampa, give the only city-level wage evidence that exists for the company. These are offered base wages and exclude bonus, equity and benefits entirely.

2025 displayed records
96
Records shown for Centene Management Company LLC in the 2025 h1bdata.info file.
2025 median wage
$138,137
Median across the 96 displayed records, close to the analytical C3 and C4 midpoints.
Records between $100k and $150k
69.8%
A further 25.0 percent sit between $150,000 and $200,000, 3.1 percent below $100,000 and 2.1 percent above $200,000.
FY2025 certified applications
115
MyVisaJobs count, with 1 withdrawn and 25 certified-withdrawn, at a $137,841 average wage.
FY2025 petition decisions
121 approved, 0 denied
A 100 percent approval rate among reported decisions; FY2024 was 116 approvals against 1 denial.
Wage trend
$125,409 to $137,841
Average H-1B salary rose across FY2023, FY2024 at $126,524 and FY2025, about 10 percent over two years.

Dataset summary

DatasetResultInterpretation
h1bdata.info, 2025 employer records96 displayed records, median $138,136.565Rows are filings or positions rather than unique workers, and the site's year filter is calendar based.
MyVisaJobs employer summary, updated 18 August 2026115 certified FY2025 applications, average $137,841Adds 1 withdrawn and 25 certified-withdrawn filings, and separately reports USCIS petition decisions.
MyVisaJobs FY2026 partial86 filings, 38 approvals and 1 denialPartial-year data that is not comparable with a completed fiscal year.

City-level H-1B wage history

CityP25MedianP75Records
St. Louis, MO
The headquarters market and the largest sample in the file, which is why it anchors this report.
$132K$140,306$146K24
Tampa, FL
Legacy WellCare technology hub; the median sits within 1 percent of St. Louis.
$140K$141,267$153K9
Wesley Chapel, FL
Small sample and the highest Florida wages in the file, about 19 percent above the anchor.
$149K$166,521$171K5
Folsom, CA
Small sample and the highest observed wage level, about 30 percent above the anchor.
$174K$182,411$191K4
Irving, TX
Small sample and the lowest observed wage level, about 9 percent below the anchor.
$117K$128,000$133K4

All-years aggregates. P25/P75 are rounded reconstruction values marked modeled; medians and record counts are the stronger fields.

Selected title / worksite records

TitleWorksiteProffered wageNotes
Business Analyst IIIrving, TX$82,650Sits inside the analytical C2 envelope and is the lowest named example in the file.
Data Analyst IVIndianapolis, IN$131,330Close to the C3 senior professional midpoint of about $113,950 and inside the posted senior analyst range.
Lead Application Development EngineerSt. Louis, MO$143,750–$160,496Multiple displayed records at the headquarters site, mapping to the C4 lead and principal band.
Lead Data EngineerTampa, FL$141,267The Tampa median is set by roles of exactly this type, which is why the Tampa factor tracks St. Louis so closely.
Director, Information TechnologyTampa, FL$207,041The highest named example and a direct cross-check on the M2 director envelope of $121,500 to $274,200.
Director of OperationsBridgeville, PA$180,000A non-technology director at a small worksite, showing the M2 spread is functional rather than geographic.

Reading the data correctly

  • These are offered base wages attached to labour condition applications. They exclude bonus, equity, benefits and any allowance, so they are a floor on cash rather than a package.
  • The two datasets disagree on the 2025 count, 96 against 115. The likely causes are fiscal versus calendar filters, employer-name matching, certification status, duplicate and amended filings and refresh timing. Neither number is a count of employees hired.
  • Visa filings overrepresent sponsored occupations. Technology, analytics and actuarial roles dominate the file, and no frontline care coordination, member services or clinical role appears in it at all.
  • Three of the five city samples rest on four or five records, so the Folsom, Wesley Chapel and Irving factors in this report should be read as directional observations rather than city pay policies.
  • A single worker can appear as several filings across amendments, extensions and transfers, so record counts overstate distinct individuals.

Key Nuances & Insights

01There is no Centene band system to negotiate against

Centene publishes a salary range on each requisition and nothing else. No grade numbering, no midpoints, no compa-ratio, no range penetration, no job-family point system. C1 to C4 and M1 to M4 exist only in this report. The practical consequence is that a candidate cannot ask where in the band an offer sits, because there is no band to sit in, only the posted range for that specific requisition.

02Two vice-president postings differ by $88,100 at the top

The 2026 Associate General Counsel range tops out at $326,900, Network Development at $343,300 and Interoperability Strategy at $431,400. Title is not the pricing unit at Centene; function and remit are. Any inference of a corporate vice-president midpoint from one or two postings is unsafe by a six-figure margin.

03Formal equity eligibility is not equity

The 2025 Stock Incentive Plan permits awards to employees, officers, directors, consultants and advisors, yet only about 2,650 employees plus 11 directors held awards at 15 March 2025 against a 61,100 year-end workforce. Roughly 4.3 percent. The honest answer to the question of a minimum band for restricted stock units is that it is not publicly disclosed, and eligibility language should never be read as an expectation.

04The ESPP is a 5 percent discount, not 15, and there is no lookback

Shares are purchased at 95 percent of the closing price on the quarterly exercise date. There is no offering-period lookback, no reset feature and no purchase at the lower of two prices, which is what makes the technology-sector plans valuable. Centene's is a modest, reliable benefit with a $2,500 quarterly fair-value cap and a 90-day holding rule, and it is still the only equity most employees will ever receive from the company.

05The annual incentive has real downside and 2025 proved it

The plan funded at 71.6 percent of target for every named executive, cutting the chief executive's cash incentive from $4.289 million to $2.109 million year on year and dragging her total down 5.3 percent even though salary and stock awards both rose. This is the clearest available evidence that Centene's committee funds on the corporate result rather than smoothing outcomes.

06The 2026 formula moves from growth to medical cost

For 2026 the 20 percent organic premium and service revenue weighting is replaced by a 20 percent Health Benefits Ratio measure, and the long-term incentive design shifts toward absolute total shareholder return. Both changes tie executive pay more tightly to medical cost control and to the share price itself, which matters after a year in which Marketplace membership fell.

07Stock awards are 79.7 percent of the chief executive's reported pay

Salary was 7.6 percent of the fiscal 2025 total. That makes the headline number a grant-date accounting valuation rather than money received, and it makes the reported figure highly sensitive to valuation assumptions, performance certification and the share price. Actual value realised on vesting in 2025 was $5,799,725, less than a third of the reported total.

08The incoming CFO package shows what a lateral costs

Christopher Neczypor's disclosed terms are $1.1 million base, a 150 percent bonus target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three annual instalments and a $2.0 million cash sign-on. The make-whole award alone is nine times base salary. It replaces forfeited equity at a prior employer and establishes nothing about a general lateral premium at any other level.

09A code F filing is not insider selling

Two of the four 2026 Form 4 events are code F tax withholdings on vesting, where the executive controls neither the timing nor the size. Only Koster's August 2026 sale of 47,603 shares for about $3.11 million is a discretionary open-market disposition. Screening tools that lump the two together will misread Centene's insider activity badly.

10The share price roughly doubled inside 2026

Asher's March 2026 tax withholding priced at $34.45 and Smith's June withholding at $65.19, against a $65.00 reference close on 25 August 2026. Employees holding unvested restricted stock units through that window saw the value of an identical unit count move dramatically, which is exactly the risk a grant-date accounting figure conceals.

11Currency conversion is not labour-market conversion

The research bundle carried selectors for Bangalore, Chennai, Hyderabad, Sydney, Manila, Auckland, Singapore and Dubai and found no current Centene employing entity behind any of them. Converting a St. Louis salary into rupees produces a rupee number, not an India salary, and vendor or business-process outsourcing personnel are not Centene employees without an employing-entity source.

12The 2023 headcount comparison is a trap

The 67,700 team members reported at the end of 2023 included roughly 8,300 Circle Health employees in a United Kingdom hospital business sold in January 2024 for about $931 million. On a comparable basis the 2023 figure is closer to 59,400, so the true trajectory is 59,400 to 60,500 to 61,100, mild growth rather than the 10 percent collapse the raw numbers suggest.

13Restructuring is the live compensation story of 2026

Broad buyout eligibility was confirmed in June 2026 after Marketplace membership losses, a voluntary separation program commenced on 27 July, and the Q2 10-Q estimates $315 million to $365 million of severance expense for the remainder of the year. None of this is a salary cut, but it changes retention economics, open requisition volume and bargaining leverage in ways a static salary table cannot show.

14Directors are paid more than directors

A non-employee board member receives $120,000 in cash plus $225,000 in restricted stock units for part-time governance work, a $345,000 package. The analytical M2 Director band, a full-time operating role, has a midpoint of about $197,850. The word means two completely different things inside the same company.

Research control

On chief executive pay Centene sits fourth of five in its managed-care comparison set, below Cigna at $22.866 million and Elevance at $22.582 million, above Molina at $18.341 million and far below UnitedHealth's $60.951 million, which carries a large one-time option award. Its 206 to 1 ratio is a function of a $94,800 median employee, a figure that reflects a workforce weighted toward care coordination, member services and claims rather than toward engineering. On the employee side, the C1 to M4 ladder is a base-salary market map with no visible bonus or equity layer, which is the structural difference between a managed-care payer and the technology employers most compensation benchmarks are built around.

Evidence classification

LabelMeaningExamples and permitted use
VerifiedA Centene SEC filing, a filed plan exhibit, an official Centene job posting or an official Centene benefits page.Executive pay, the pay ratio, equity plan mechanics, ESPP terms, benefit categories, headcount, board pay and every band's posted salary endpoints.
ReportedA named third-party dataset with observable records, chiefly the 2025 labour condition application files and, for directional checks only, salary platforms.City wage percentiles, the four city calibration factors and the role-level cross-checks against the analytical bands.
ModeledAn arithmetic midpoint across official postings, or the St. Louis midpoint scaled by an observed city factor, shown inside a planning envelope.The C2 through M4 band midpoints, which join several distinct roles, and every city cell outside St. Louis.
Not publicly disclosedNo source in the research bundle supports a figure, and none is estimated.Every employee bonus target, every employee equity grant value, the 401(k) match formula, the rating scale and the merit matrix.

Explicit “Not publicly disclosed” index

Any employee bonus target, cadence, weighting or payout history below the named executive tier
Any employee equity grant value, grant frequency or minimum eligible level
The current 401(k) match percentage and its vesting schedule
Paid-time-off day counts by tenure, and the employer share of medical premiums
Tuition reimbursement, adoption reimbursement and volunteer hour limits
Performance rating scale, distribution, merit matrix and enterprise review effective date
Time in band and promotion increase percentage at every level
Headcount by city, state, function or country
Attrition rate for any recent year
Any 2025 or 2026 companywide salary increase, freeze, cut or campus offer revision
A quantitative adjusted pay-gap or band-level pay-equity table
City differential schedule of any kind

Known gaps and diligence before relying on a cell

  1. 1The three executive rows are kept inside the band table but are marked chart-excluded, and because every priced market in this report is in the United States at a fixed factor there is no seniority interpolation anywhere. No offshore cell is therefore distorted by a global executive figure, which is the usual failure mode when proxy rows sit in an employee ladder.
  2. 2Bonus and equity are recorded as zero for every band from C1 through M4, so total compensation equals base salary for those rows. That is a disclosure gap, not a finding that Centene pays no bonus. Postings state that additional incentives may apply and give no way to size them.
  3. 3No employer benefit load is added to any total in this report. Centene's benefits are economically material but cannot be valued from public plan summaries, and adding a notional 8 to 15 percent would convert employer cost into pay.
  4. 4Seventeen of the twenty-one markets sit at the anchor factor of 1.00 because no wage observation exists for them. This reflects Centene's own stated position that pay is set by the posting rather than by the city, and it should not be read as a finding that Sacramento and Great Falls pay the same.
  5. 5The two visa datasets disagree on the 2025 count, 96 displayed records against 115 certified applications, and this report presents both rather than reconciling them, because labour condition applications, prevailing-wage requests and petitions are different processes with different denominators.
  6. 6The chief executive pay ratio uses $19,516,298 while the Summary Compensation Table shows $19,506,298. The $10,000 difference is a medical benefits adjustment inside the ratio calculation and both figures are disclosed as filed.
  7. 7The 2,650 award-holder count is dated 15 March 2025 while the 61,100 headcount is dated 31 December 2025. The resulting 4.3 percent participation figure is indicative only.
  8. 8The equity plan tables cannot yield a single pool utilisation rate, because authorised shares, outstanding full-value awards, legacy assumed awards and future availability do not share a common denominator across the plans they cover.
  9. 9A crowd-reported 401(k) match of 50 percent on the first 6 percent could not be traced to a current authoritative plan document and is excluded from the verified benefit rows.
  10. 10The board retainer increase is dated to February 2026 in the proxy without a day, and the news entry carries the first of that month as a placeholder date.
  11. 11Approximate 2025 revenue of about $195 billion appears in the bundle without a filing citation and is therefore not carried in any metric in this report.
  12. 12No exchange rate other than USD is used anywhere, because no Centene pay in any other currency was verified. The bundle's own report-date table of INR 95.4191, AUD 1.3924, GBP 0.7334, EUR 0.8573, PHP 61.5706, NZD 1.6792, SGD 1.2700 and AED 3.6725 per US dollar is recorded here for completeness only.

Source register — 42 sources

S12025 Form 10-K, year ended 31 December 2025 · US Securities and Exchange Commission / Centene · 2025-12-31. 61,100 team members, workforce philosophy, benefit categories, equity accounting, subsidiary and divestiture context, ESPP balances
S22026 definitive proxy statement · US Securities and Exchange Commission / Centene · 2026-03-26. Fiscal 2025 named executive pay, pay ratio, incentive targets and 71.6 percent funding, LTI mix, director pay, internal-fill statistic, ICHRA pilot
S32025 definitive proxy and 2025 Stock Incentive Plan proposal · US Securities and Exchange Commission / Centene · 2025-03-27. Plan award types, 15,000,000 share authorisation, minimum vesting, and the 2,650 employee plus 11 director award-holder count
S42024 Form 10-K · US Securities and Exchange Commission / Centene · 2024-12-31. 60,500 headcount and the Circle Health disposal context
S52023 Form 10-K · US Securities and Exchange Commission / Centene · 2023-12-31. 67,700 headcount including roughly 8,300 Circle Health employees
S6Q2 2026 Form 10-Q, quarter ended 30 June 2026 · US Securities and Exchange Commission / Centene · 2026-06-30. Voluntary separation program from 27 July 2026 and the $315 million to $365 million severance estimate
S7Form 8-K on chief financial officer succession · US Securities and Exchange Commission / Centene · 2026-08-12. Neczypor base, bonus target, 2027 LTI target, make-whole restricted stock units and cash sign-on
S82002 Employee Stock Purchase Plan, filed exhibit · US Securities and Exchange Commission / Centene · 2019-06-30. ESPP eligibility, contribution range, quarterly offering mechanics, 95 percent purchase price and holding rule
S92020 ESPP amendment · US Securities and Exchange Commission / Centene · 2020-04-30. ESPP amendment history and reserved-share changes
S10Care Coordinator III posting, Bedford and remote New Hampshire · Centene Careers · 2026-08-21. $20.39 to $34.71 an hour and the two-to-four-year experience clue behind the C2 floor
S11Senior Business Technical Analyst posting, remote Missouri · Centene Careers · 2026-07-11. $87,700 to $157,800, the primary C3 anchor
S12Senior Business Solutions Architect posting, remote Florida · Centene Careers · 2026-07-14. $107,700 to $199,300, the C4 floor
S13Vice President, Network Development and Contracting posting, remote Michigan · Centene Careers · 2026-05-18. $180,400 to $343,300 vice-president anchor
S14Vice President, Interoperability Strategy and Operations posting, remote North Carolina · Centene Careers · 2026-08-25. $227,700 to $431,400, the M4 ceiling and the most recent posting in the set
S15Life at Centene benefits page · Centene Careers · 2026-08-26. Medical, disability, 401(k) match, ESPP, leave, tuition, Centene University and flexible work categories
S16Culture, talent and well-being page · Centene · 2026-08-26. Centene University reach, workforce development, internal mobility and employee networks
S17Centene Management Company LLC 2025 records · h1bdata.info · 2026-08-26. 96 displayed records, $138,137 median, wage distribution, city quartiles and role examples
S18Centene Management employer summary, FY2023 to FY2026 · MyVisaJobs · 2026-08-18. Certified application counts, petition approvals and denials, and annual average wages
S19Report on Centene buyout offers after Marketplace losses · Reuters · 2026-06-15. Broad buyout eligibility, about 61,000 employees at the end of Q1 2026, commercial revenue down 6 percent and membership around 26.3 million
S20Daily exchange rates table · Reserve Bank of Australia · 2026-08-26. The report-date foreign-exchange convention recorded in known gaps; no Centene pay is converted
S21Form 4, Sarah London award of 520,720 securities · US Securities and Exchange Commission · 2026-01-26. RSU and PSU tranches, vesting and certification through March 2029
S22Form 4, Andrew Asher code F disposition · US Securities and Exchange Commission · 2026-03-15. 15,241 shares withheld at $34.45 for taxes on vesting
S23Form 4, Susan Smith code F disposition · US Securities and Exchange Commission · 2026-06-15. 483 shares withheld at $65.19 for taxes on vesting
S24Form 4, Christopher Koster code S sale · US Securities and Exchange Commission · 2026-08-18. 47,603 shares sold at a weighted average $65.36 with executions from $65.28 to $65.45
S25Elevance Health 2026 definitive proxy · US Securities and Exchange Commission / Elevance Health · 2026-03-26. Gail Boudreaux fiscal 2025 total compensation of $22.582 million
S26The Cigna Group 2026 definitive proxy · US Securities and Exchange Commission / The Cigna Group · 2026-03-12. David Cordani fiscal 2025 total compensation of $22.866 million
S27Molina Healthcare 2026 definitive proxy · US Securities and Exchange Commission / Molina Healthcare · 2026-03-13. Joseph Zubretsky fiscal 2025 total compensation of $18.341 million
S28UnitedHealth Group 2026 definitive proxy · US Securities and Exchange Commission / UnitedHealth Group · 2026-04-01. Stephen Hemsley fiscal 2025 total of $60.951 million including a large one-time option award
S29Historical market data, 25 August 2026 close · Centene Investor Relations · 2026-08-25. The $65.00 reference price used only for clearly labelled illustrative valuations
S30Report on a reduction of about 2,000 jobs · Reuters · 2023-09-26. The 2023 restructuring that complicates raw headcount comparisons
S32Centene software engineer salary page · Levels.fyi · 2026-08-26. Directional check on C2 to C4, showing roughly $78,000 to $156,000 and a displayed median package around $130,000
S33Centene Director salary page · Glassdoor · 2026-08-26. Directional check on M2, showing an estimated average around $219,700 and submissions from roughly $148,000 to $246,000
S34Centene Corporation employer salary page · PayScale · 2026-05-28. Broad sanity check at an $81,598 company average across a 297-report sample
S35Centene role salary pages · Indeed · 2026-08-26. Directional title checks at about $144,700 for Director, $129,000 for Manager, $80,400 for Data Analyst and $126,600 for Senior Software Engineer
S36Director of Operations salary estimate · Comparably · 2026-08-26. The only public bonus split for a non-executive role, at $154,755 base plus $29,726 bonus, treated as directional only
S37Care Coordinator II posting · Centene Careers · 2026-08-14. $17.84 to $28.02 an hour, the C1 frontline anchor
S38Principal Incident Response Analyst posting · Centene Careers · 2026-07-14. $121,500 to $224,900, the C4 ceiling
S39Manager, Provider Data Management posting · Centene Careers · 2026-08-24. $70,100 to $126,200, the lower M1 manager anchor
S40Senior Manager, Product Performance posting · Centene Careers · 2026-08-25. $107,700 to $199,300, the upper M1 anchor
S41Senior Director, Healthcare Analytics posting · Centene Careers · 2026-08-20. $134,600 to $249,000, the lower M3 anchor
S42Senior Director, Pharmacy posting · Centene Careers · 2026-08-12. $185,700 to $352,500, the upper M3 anchor with California and licensed-clinical scope
S43Vice President, Associate General Counsel posting · Centene Careers · 2026-08-17. $171,900 to $326,900, the lower M4 anchor

Recent News & Workforce Trend

Centene's 2026 has been dominated by workforce reduction and a chief financial officer succession rather than by a pay increase. No companywide salary action was announced in any reviewed source, and the only enterprise-scale compensation event on record is severance.

67,700
2023 employees
Included about 8,300 Circle Health employees in the United Kingdom; roughly 59,400 on a comparable basis.
60,500
2024 employees
First year-end after the Circle Health divestiture closed in January 2024.
61,100
2025 employees
Up about 600 year on year, the only year of growth in the series.
~61,000
Q1 2026 employees
Reported alongside total health-plan membership of about 26.3 million, down 6 percent year on year.

On a comparable basis Centene has been broadly flat at just under 61,000 people for three years, and the apparent 2023 to 2024 collapse is an artefact of divesting a hospital business rather than a reduction in the core workforce. That flat line is about to break: the voluntary separation program that commenced on 27 July 2026 carries $315 million to $365 million of estimated severance expense for the remainder of the year, and no audited year-end 2026 count exists yet. Centene reports total team members only, with no split by office, state, country or function.

18 Aug 2026
General Counsel sells 47,603 shares on the open market

Christopher Koster disposed of 47,603 shares at a weighted average $65.36, about $3.11 million, with executions between $65.28 and $65.45. It is the only discretionary insider sale in the 2026 window and came three weeks after the voluntary separation program commenced.

SEC Form 4
12 Aug 2026
Chief financial officer succession with a $10.0 million make-whole award

Andrew Asher will retire as chief financial officer on 31 December 2026 and serve as strategic advisor through 2027. Christopher Neczypor joins as executive vice president around 1 September 2026 and becomes chief financial officer on 1 January 2027 on $1.1 million base, a 150 percent bonus target capped at 200 percent of target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three equal annual instalments and a $2.0 million cash sign-on payment.

Centene Form 8-K
27 Jul 2026
Voluntary separation program commences

The Q2 2026 Form 10-Q records vendor and severance optimisation costs and estimates $315 million to $365 million of severance expense for the remainder of 2026. It is the largest single compensation-related number Centene disclosed in 2026.

Centene Q2 2026 Form 10-Q
15 Jun 2026
Broad employee buyout eligibility confirmed

Centene confirmed separation-package eligibility for most staff following Marketplace membership losses. Contemporaneous reporting put commercial revenue down 6 percent in the first quarter, total health-plan membership around 26.3 million and headcount around 61,000.

Reuters and Centene filings
26 Mar 2026
2026 proxy shows the annual incentive funded at 71.6 percent

Every named executive was paid at 71.6 percent of target with no individual adjustment, cutting the chief executive's cash incentive to $2,109,446 from $4,289,000 a year earlier. The same filing discloses the 206 to 1 pay ratio against a $94,800 median employee and confirms the 2026 shift to a Health Benefits Ratio metric.

Centene 2026 definitive proxy statement
1 Feb 2026
Board retainers increased for the first time in the series

Effective February 2026 the annual cash retainer rose from $100,000 to $120,000, the independent chair's additional cash from $90,000 to $95,000 and selected committee-chair retainers to $25,000. The $225,000 annual restricted stock unit award was left unchanged. The proxy gives the month without a day.

Centene 2026 definitive proxy statement
26 Jan 2026
Chief executive granted 520,720 securities

Sarah London's award comprised 138,859 three-year restricted stock units, 69,429 five-year restricted stock units and 312,432 target performance share units settling between zero and 200 percent, with certification and vesting running through March 2029.

SEC Form 4
31 Dec 2025
Fiscal 2025 closes with 61,100 team members and $204 million of stock compensation expense

The 10-K reports 61,100 team members, $204 million of 2025 stock compensation expense with $356 million unrecognised over about 2.1 years, roughly 8.836 million restricted stock units granted against 2.593 million vested, and 2,129,451 ESPP shares remaining after about 796,000 were issued during the year.

Centene 2025 Form 10-K
27 Mar 2025
2025 Stock Incentive Plan put to stockholders

The plan was approved during 2025 with 15,000,000 shares initially authorised, permitting options, stock appreciation rights, restricted stock, restricted stock units, performance share units and other stock-based awards under a one-year minimum vesting rule with limited exceptions.

Centene 2025 definitive proxy statement
15 Mar 2025
About 2,650 employees hold equity awards

The plan proposal discloses roughly 2,650 employee award-holders plus 11 directors at this date, against a workforce that closed the year at 61,100. It is the single clearest measure of how selective Centene's employer-granted equity is.

Centene 2025 definitive proxy statement
12 Jan 2024
Circle Health Group divestiture closes for about $931 million

The United Kingdom hospital business, which carried roughly 8,300 employees, was sold. Together with earlier Spanish and Central European divestitures it removed the last material non-United States employing footprint from the group.

Centene 2025 Form 10-K
26 Sep 2023
About 2,000 jobs cut, roughly 3 percent of the workforce

The reduction predates the Circle Health divestiture and is one of two structural changes that make raw year-on-year headcount comparisons for 2023 and 2024 unreliable.

Reuters
Last updated 2026-08-27